Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma

// Celina Ang 1 , Samuel J. Klempner 2 , Siraj M. Ali 3 , Russell Madison 3 , Jeffrey S. Ross 3 , Eric A. Severson 3 , David Fabrizio 3 , Aaron Goodman 4 , Razelle Kurzrock 4 , James Suh 3 and Sherri Z. Millis 3 1 Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA 2 Department of Medicine, Division of Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA 3...